Conflict of Interest statement
FW, YP, JB, MK, SB, JR, AS, JW, LL, JH declare no relevant conflict of
interest. AEP has received research funding from AbbVie, Inc. SP
receives support for the conduct of clinical trials through Boston
Children’s Hospital from AlloVir, Atara, and Jasper, SP provides
consulting (CellEvolve, Pierre Fabre) and receives honoraria from
Regeneron, SP is an Inventor related to development of third party viral
specific T cells program with all rights assigned to Memorial Sloan
Kettering Cancer Center. JAP receives support for the conduct of
clinical trials through Boston Children’s Hospital / Dana-Farber Cancer
Institute from AbbVie, Ymab Therapeutics and Servier and is on the
advisory board for foresee pharmaceuticals.